Term
What is the goal of drug delivery? |
|
Definition
To: Deliver the drug intact In the right amount At the right place At the right time |
|
|
Term
Five Basic Medication Errors |
|
Definition
Wrong Drug Wrong Dose Wrong Route Wrong Time Wrong Patient |
|
|
Term
Go through the flow of a drug in a person's body, starting with only the drug and inert additional substances? |
|
Definition
Drug+inert additional substances go into absorption into the body and "bio availability". This then goes into the distribution into compartments- then that goes to either metabolism or pharmalogical action. |
|
|
Term
What is are the problems of drugs? |
|
Definition
Poor solubility Tissue Damage on Extravasation Rapid Breakdown of the drug in Vivo unfavorable PK Poor Biodistribution |
|
|
Term
What is an implication of poor solubility |
|
Definition
A convenient pharmaceutical format is difficult to achieve, as hydrophobic drugs may precipitate in aqueous media. Toxicities are associated with the use of excipients such as cremophor (the solubilizer for paclitaxel in Taxol) |
|
|
Term
What is the implication of tissue damage on extravasation |
|
Definition
Inadvertent extravasation of cytotoxic drugs that leads to tissue damage (example is tissue necrosis with free doxorubicin) |
|
|
Term
What is the implication of unfavorable Pk? |
|
Definition
This is when drug is cleared too rapidly, by the kidney, for example, requiring high doses or continuous infusion. |
|
|
Term
What is the implication of Poor biodistribution? |
|
Definition
The drugs that have widespread distribution in the body can affect normal tissues, resulting in dose-limiting side effects, such as cardiac toxicity of doxorubicin. |
|
|
Term
What are effects of DDS on poor solubility? |
|
Definition
DDS such as lipid micelles or liposomes provide both hydrophillic and hydrophobic environments and enhancing drug solubility |
|
|
Term
What are the effects of DDS on tissue damage on extravasation? |
|
Definition
Regulated drug release from the DDS can reduce or eliminate tissue damage on accidental extravasation |
|
|
Term
What are the effects of DDS on the rapid breakdown of the drug in vivo? |
|
Definition
DDS protects the drug from premature degradation and functions as a sustained release system. Lower doses of the drug are required. |
|
|
Term
What are the effects of DDS on unfavorable pharmacokinetics? |
|
Definition
DDS can substantially alter the PK of the drug and reduce the clearance. Rapid renal clearance of small molecules is avoided. |
|
|
Term
What are the effects of DDS on poor biodistribution? |
|
Definition
The particulate nature of DDS lowers the volume of distribution and helps to reduce side effects in sensitive, non-target tissues. |
|
|
Term
How can DDS can increase the drug concentrations in disease tissues such as tumors? |
|
Definition
This is done by the EPR effects. Ligand-mediated targeting of the DDS can further improve the drug specificity. |
|
|
Term
What are key considerations in drug delivery? |
|
Definition
The drug "personality" Dose/quantity/accuracy drug bioavailability drug stability manufacturable Product acceptance +convenience + compliance +acute/chronic |
|
|
Term
What are elements of Drug delivery? |
|
Definition
|
|
Term
What is a drug "personality" |
|
Definition
Each drug has intrinsic chemical and physical characteristics that must be considered before the start of a formulation |
|
|
Term
What aspects are involved in a drug personality? |
|
Definition
Solubility partition coefficient dissolution rate physical form stability |
|
|
Term
What are characteristics of excipients? |
|
Definition
They promote manufacturablity promote stability Promote bioavailability Promote accurate dosing Promote patient acceptance and convenience mostly inert route? Impact therapy? |
|
|
Term
|
Definition
Immediate release of one dose delayed release of one dose, then full release (enteric coated tablets) Prolonged release of enough drug to increase intervals between dosing (once a day to once a year) controlled release- spatial and temporal control |
|
|
Term
What are the major dosage forms? |
|
Definition
*solids* powders capsules tablets implants *Liquids* solutions suspensions *semi-solids* ointments creams suppositories |
|
|
Term
what is the pathway to get the best dissolution? |
|
Definition
Tablet disintegrates to granules which disintegrate to small particles and then goes to best dissolution. |
|
|
Term
What are systemic drug delivery? |
|
Definition
*oral route* *intravenous route* *other routes* IM or SC routes transdermal route sublingual or buccal routes intranasal route pulmonary route |
|
|
Term
Where are the local drug deliveries? |
|
Definition
Skin ears, eyes, nose, and throat lungs rectal, vaginal, and urethral routes perfusion of organs- liver and brain |
|
|
Term
What are the major goals of local drug delivery? |
|
Definition
minimum systemic absorption optimal drug concentration reaches local site |
|
|
Term
|
Definition
Disease and the drug Access of the site of action Retention, does it stay there Timing of the drug |
|
|
Term
|
Definition
polymeric drug or sequestrant polymer-protein conjugate polyplex polymer-DNA complex polymer-drug conjugate polymeric micelle |
|
|
Term
What are physiochemical propertices of drug influencing drug absorption? |
|
Definition
*lipid solubility* partition coefficient *PKA* henderson-hasselbach equation *Molecular weight and volument* stokes-einstein equation *aqueous solubility* dissolution rate limited *chemical stability* |
|
|
Term
|
Definition
molecular weight is greater than 500 log k (coctanol/c water) greater than 5 greater than 5 hydrogen bond donors greater than 10 hydrogen bond acceptors |
|
|
Term
What are ways of carrier-mediated transport? |
|
Definition
Involves a protein that spans a biological membran
active transport against a concentration gradient
facilitate diffusion with a concentration gradient
specificity saturation competition the small intestine has a wide variety of transporters- AA, ogliopeptide, glucose and lactic acid levodopa, methyldopa, and penicillamine are absorbed by AA transporters. |
|
|
Term
Give me characteristics of capillaries during trans-endothelial transport- extravasation? |
|
Definition
*continuous: connective tissue, skin, muscle, and most other tissue in the body. serum albumin barely pass
*fenestrated: GI tract, glands, and renal glomerulus, endothelia have openings, fenestrae and clefts sinusoidal- liver, spleen and bone marrow. Have cleffts of 100 nm and no basement membrane like the others BBB- cells of these tight endothelium have few vesicles and their intercellular junctions are closed by belts in the tight junctions. |
|
|
Term
Give me characteristics of BBB during trans-endothelial transport- extravasation? |
|
Definition
*lipophillic route through cell membrane *carrier-mediated uptake *carrier-mediated efflux *drug efflux transporters operating in a luminal membrane, including PGP *paracellular transport through hydrophllic pathway *endocytosis and transcytosis via vesicular pathways. |
|
|
Term
definition of a dispersed system? |
|
Definition
in a pharm preparation- the particle distributed (ie undissolved or immiscible drug) is referred to as the dispersed phase and the vehicle is termed the disperising phase or dispersing medium. |
|
|
Term
What are the types of dispersions? |
|
Definition
course dispersion- particle range in size from 10 to 50 micrometer (suspension and emulsions)
fine dispersions: particles range from 0.5 to 10 micrometers (gels)
colloidal dispersion: particles in the nanometer range |
|
|
Term
What are the three types of pharmaceutical mixture? |
|
Definition
solutions dispersions (powder blends) dispersions (particles in liquid) |
|
|
Term
What are characteristics of solutions? |
|
Definition
molecularly dispersed spatially homogenous thermodynamically stable (delta g=0) |
|
|
Term
What are the characteristics of power blend dispersions? |
|
Definition
particles dispersed within other particles they are not spatially homogenous they are thermodynamically unstable (2 or more phases) |
|
|
Term
Dispersions of particles in a liquid, what are the 3 general physical instability problems? |
|
Definition
nonwetting- solid particles don't disperse uniformly when placed into the liquid
aggregation/coalescence- particles aggregate to form larger agglomerates or, if liquid-liquid or vapor-liquid, they coalesce
sedimentation/creaming-particles (liquid, vapor, solid) sedmin or cream due to gravitational effects and density differences.
all these lead to a nonuniformity of particle dispersion within the liquid. |
|
|
Term
What are characteristics of liquid dispersions and give examples of pharmaceutical interest |
|
Definition
particles dispersed in a liquid phase they are not always spatially homogeneous they are thermodynamically unstable (2 or more phases)
examples are suspension- solid in liquid emulsions- liquid in liquid forms- vapor in liquid |
|
|
Term
What are pharmaceutical uses of liquid dispersions? |
|
Definition
suspensions- parenterally, orally, topically, ophthalmically, otically
emulsions- primarily topically, also prolonged release parenterals (vaccines)
foams: topically, rectally, vaginally |
|
|
Term
Advantages of suspensions relative to solutions? |
|
Definition
They prolongs chemical stability of the drug
they can provide prolonged (sustained) release
Useful for administering less soluble drugs in convenient volumes (antibiotics administered orally, erythro ethylsuccinate) |
|
|
Term
Dispersion of powder particles in a liquid |
|
Definition
involve mixing solids with liquids
particles will not mix uniformly with the liquid (we say that they are not "wetted" float on the surface agglomerate stick to the container |
|
|
Term
|
Definition
surface tension= change in work/change in area |
|
|
Term
surface tension- highest is...? |
|
Definition
surface tension of water (72) |
|
|
Term
What is the nrgetic state of molecules at the surface relative to the bulk? |
|
Definition
*unsatisfied valence forces are exposed @ surface resulting in higher nrg per molecule
*moelcules @ the surface respond by having fewer molecules per unit volume of surface than in the bulk phase
*molecules at the surface orient so as the reduce energetic differences with the another phase (vapor, liquid, or solid) |
|
|
Term
impact of surface tension on wettability of solids |
|
Definition
solids and liquids with sufficiently similiar surface tensions will be compatible even if they do not dissolve "good wetting" (silica, sio2, in water)
*solids and liquids with very different durface tensions will not wet very well (teflon in water certain hydrophobic drugs and exicipients) |
|
|
Term
Less contact angle from solid and vapor, the better? |
|
Definition
yes, the better the wetting. |
|
|
Term
What is the equation relating work with overall free nrg? |
|
Definition
delta G= surface tension*change in area
the higher the surface tension and area, the greater the work (more positive the free nrg) |
|
|
Term
The (bigger or smaller) the delta G, the better the extent of wetting? |
|
Definition
|
|
Term
To promote wetting, which surface tensions must be high and which must be low? |
|
Definition
the lower the SL, the Lower LV, the higher the SV |
|
|
Term
How can be promote wetting? |
|
Definition
coat the solid with other polar solids to raise the SV
use surface active agents to lower the LV and SL |
|
|
Term
What is the difference between surface tension and interfacial tension? |
|
Definition
Surface tensions= f/l this is used specifically to describe liquid-vapor and solid vapor systems
interfacial tension= f/l (broader) mostly used to describe immiscible liquis-liquid, liquid-solid, solid-solid systems strength of y is proportional to strength of intermolecular interactions in each phase |
|
|
Term
What does increasing the ratio for cos theta do to the angle? |
|
Definition
it decreases the angle (makes it closer to zero) |
|
|
Term
What is the young equation? |
|
Definition
Cos theta= (surface tension (SV)- Surface tension (sl))/surface tension (LV) |
|
|